To our knowledge, Coupland et al. were the first attempting to investigate the role of MAPT-AS1 in the regulation of Tau expression in the context of neurodegeneration, specifically in Parkinson’s disease [21]. This evidence concerns the gene MAPT and Parkinson disease.